Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CI 920

Known as: CI-920 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Fostriecin (CI-920) is a potent inhibitor of protein phosphatase 2A (PP2A) and protein phosphatase 4(PP4) found to have… Expand
Is this relevant?
2001
2001
Fostriecin (CI-920, 1; see Scheme 1) is a structurally interesting antitumor agent that was first isolated in 1983 by scientists… Expand
Is this relevant?
2001
2001
The first total synthesis of the potent antitumor agent fostriecin (CI-920) is described, confirming the relative and absolute… Expand
  • figure 1
Is this relevant?
1995
1995
This laboratory previously described an L1210 murine leukemia cell line with a functional defect in the reduced folate carrier… Expand
Is this relevant?
1986
1986
A human tumor cloning assay was utilized to evaluate the antineoplastic activity of the novel antitumor antibiotic fostriecin (CI… Expand
Is this relevant?
1985
1985
CI-920 is a structurally novel, phosphate-containing polyene lactone antitumor agent isolated from a previously undescribed… Expand
Is this relevant?
1984
1984
Cl-920 is a structurally novel phosphate ester antibiotic that contains an unsaturated lactone and a conjugated triene system. It… Expand
Is this relevant?
1984
1984
SummaryBiochemical studies on a new antitumor antibiotic, CI-920, have been directed toward understanding its mode of action. The… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
1983
1983
A complex of structurally related compounds that exhibit in vivo antileukemic activity was isolated from fermentation broths of a… Expand
Is this relevant?
1983
1983
CI-920 (PD 110,161) and two analogues (PD 113,270 and PD 113,271) are novel antitumor compounds produced by a new actinomycete… Expand
Is this relevant?